Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41
暂无分享,去创建一个
C. Bewley | G. Clore | D. E. Anderson | J. Louis | A. Wlodawer | A. Gustchina | Mi Li | C. Frisch | E. Gustchina | J. Lloyd
[1] D. Montefiori,et al. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates , 2010, Proceedings of the National Academy of Sciences.
[2] Q. Sattentau,et al. Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals , 2010, PloS one.
[3] M. Root,et al. Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding , 2009, PLoS pathogens.
[4] J. Condra,et al. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41 , 2009, mAbs.
[5] Susan Jones,et al. ProtorP: a protein-protein interaction analysis server , 2009, Bioinform..
[6] J. Condra,et al. Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41. , 2008, AIDS research and human retroviruses.
[7] D. Eckert,et al. Characterization of the steric defense of the HIV‐1 gp41 N‐trimer region , 2008, Protein science : a publication of the Protein Society.
[8] C. Bewley,et al. Sequestering of the Prehairpin Intermediate of gp41 by Peptide N36Mut(e,g) Potentiates the Human Immunodeficiency Virus Type 1 Neutralizing Activity of Monoclonal Antibodies Directed against the N-Terminal Helical Repeat of gp41 , 2008, Journal of Virology.
[9] D. Richman,et al. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. , 2008, Virology.
[10] B. Haynes,et al. Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody That Recognizes a Novel Conformational Epitope on gp41 and Lacks Reactivity against Self-Antigens , 2008, Journal of Virology.
[11] A. Honegger,et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. , 2008, Journal of molecular biology.
[12] C. Bewley,et al. A Monoclonal Fab Derived from a Human Nonimmune Phage Library Reveals a New Epitope on gp41 and Neutralizes Diverse Human Immunodeficiency Virus Type 1 Strains , 2007, Journal of Virology.
[13] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[14] S. Rybak,et al. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. , 2007, Virology.
[15] C. Bewley,et al. Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41. , 2006, Journal of molecular biology.
[16] M. Root,et al. Kinetic Dependence to HIV-1 Entry Inhibition* , 2006, Journal of Biological Chemistry.
[17] M. Luftig,et al. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody , 2006, Nature Structural &Molecular Biology.
[18] C. Bewley,et al. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41. , 2005, Journal of molecular biology.
[19] Gennaro Ciliberto,et al. A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Hummer,et al. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. , 2005, Journal of medicinal chemistry.
[21] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[22] M. Root,et al. HIV-1 gp41 as a target for viral entry inhibition. , 2004, Current pharmaceutical design.
[23] Michael Greenberg,et al. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes , 2004, Nature Reviews Drug Discovery.
[24] Martin Gilar,et al. Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. , 2003, Analytical chemistry.
[25] S. A. Gallo,et al. The HIV Env-mediated fusion reaction. , 2003, Biochimica et biophysica acta.
[26] C. Bewley,et al. Covalent Trimers of the Internal N-terminal Trimeric Coiled-coil of gp41 and Antibodies Directed against Them Are Potent Inhibitors of HIV Envelope-mediated Cell Fusion* , 2003, Journal of Biological Chemistry.
[27] S. Zolla-Pazner,et al. Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates , 2002, Journal of Virology.
[28] G. Marius Clore,et al. Design of a Novel Peptide Inhibitor of HIV Fusion That Disrupts the Internal Trimeric Coiled-coil of gp41* , 2002, The Journal of Biological Chemistry.
[29] Paul W. H. I. Parren,et al. Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 , 2001, Journal of Virology.
[30] P. S. Kim,et al. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Bewley,et al. Design and Properties of NCCG-gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory Activity* , 2001, The Journal of Biological Chemistry.
[32] Michael S. Kay,et al. Protein Design of an HIV-1 Entry Inhibitor , 2001, Science.
[33] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[34] G. Melikyan,et al. Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion , 2000, The Journal of cell biology.
[35] Brian T. Foley,et al. HIV Sequence Compendium 2018 , 2010 .
[36] P. S. Kim,et al. Inhibiting HIV-1 Entry Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket , 1999, Cell.
[37] G. Marius Clore,et al. Improving the Packing and Accuracy of NMR Structures with a Pseudopotential for the Radius of Gyration , 1999 .
[38] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[39] A. Gronenborn,et al. Three‐dimensional solution structure of the 44 kDa ectodomain of SIV gp41 , 1998, The EMBO journal.
[40] C. Weiss,et al. Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.
[41] P. S. Kim,et al. HIV Entry and Its Inhibition , 1998, Cell.
[42] C. Weiss,et al. Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.
[43] K. Tan,et al. Atomic structure of a thermostable subdomain of HIV-1 gp41. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Harrison,et al. Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.
[45] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[46] Deborah Fass,et al. Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.
[47] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[48] T. Matthews,et al. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] Shibo Jiang,et al. HIV-1 inhibition by a peptide , 1993, Nature.
[50] T. Oas,et al. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.
[52] J R Yates,et al. Protein sequencing by tandem mass spectrometry. , 1986, Proceedings of the National Academy of Sciences of the United States of America.